Copyright
©The Author(s) 2021.
World J Diabetes. Oct 15, 2021; 12(10): 1704-1718
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1704
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1704
Experimental model | CaMKII alterations | Functional effects | Ref. |
Sucrose-fed Sprague-Dawley rats (32% 10 wk) | ↑ CaMKII activity (autocamtide phosphorylation) | ↓ PLN-Thr17 phosphorylation | Vasanji et al[52] |
Fructose-fed Wistar rats (10%, 3 wk) | ↑ CaMKII oxidation; ↔ CaMKII expression | ↑ RyR2-Ser2814 phosphorylation | Sommese et al[55] |
Sucrose-fed Wistar rats (30%, 4 mo) | ↑ CaMKII-Thr287 phosphorylation; ↔ CaMKII expression | ↑ RyR2-Ser2814 phosphorylation | Romero-García et al[48] |
HFD Long-Evans rats treated with STZ (40% lard, 21 wk) | ↔ CaMKII-Thr287 phosphorylation; ↔ CaMKII expression | ↔ PLN-Thr17 phosphorylation | Koncsos et al[62] |
- Citation: Gaitán-González P, Sánchez-Hernández R, Arias-Montaño JA, Rueda A. Tale of two kinases: Protein kinase A and Ca2+/calmodulin-dependent protein kinase II in pre-diabetic cardiomyopathy. World J Diabetes 2021; 12(10): 1704-1718
- URL: https://www.wjgnet.com/1948-9358/full/v12/i10/1704.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i10.1704